Royal Jelly Propolis (Apis mellifera 'Royal Jelly')

Royal Jelly Propolis is a bee-derived compound combining royal jelly proteins (including major royal jelly proteins MRJPs) and propolis flavonoids such as chrysin and galangin, which exert antimicrobial, antioxidant, and lipid-modulating effects. Its primary mechanism involves inhibiting microbial enzyme activity, scavenging free radicals via phenolic compounds, and modulating cholesterol biosynthesis pathways.

Origin & History

Royal jelly is a nutritious secretion produced by honeybee worker glands, containing primarily proteins, lipids, carbohydrates, and sugars. Propolis is a resinous substance collected by bees from plant sources and processed in the hive, characterized by antimicrobial, anti-inflammatory, and antioxidant activities. Both are bee-derived products traditionally used in apitherapy and increasingly studied for therapeutic applications.

Historical & Cultural Context

The research describes royal jelly and propolis as bee-derived products traditionally used in apitherapy. While specific historical details are not provided in the available studies, these substances are noted as natural products with established traditional use that are increasingly studied for therapeutic applications.

Health Benefits

• Cardiovascular support in chronic kidney disease: Clinical trial (n=38) showed significant reductions in total cholesterol and prevented increases in urea and creatinine levels (moderate evidence)
• Antimicrobial activity: In vitro studies demonstrated significant inhibitory effects on Encephalitozoon intestinalis spore growth at non-cytotoxic concentrations (preliminary evidence)
• Antioxidant protection: Contains flavonoids (quercetin, kaempferol, pinocembrin, galangin) and phenolic acids with established antioxidant properties (preliminary evidence)
• Anti-inflammatory potential: Meta-analysis examined effects on high-sensitivity C-reactive protein (hs-CRP), though specific results not detailed (preliminary evidence)
• Synergistic effects when combined: Royal jelly and propolis demonstrate synergy with improvements in antioxidant and antimicrobial activity (preliminary evidence)

How It Works

Royal Jelly Propolis exerts antimicrobial activity through flavonoids—particularly galangin and chrysin—which disrupt microbial cell membrane integrity and inhibit ATP-synthesis enzymes in pathogens. Its antioxidant action involves direct free radical scavenging via phenolic hydroxyl groups and upregulation of endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase. Lipid-lowering effects are thought to involve inhibition of HMG-CoA reductase activity and modulation of LDL oxidation, contributing to reduced total cholesterol observed in clinical settings.

Scientific Research

The most robust evidence comes from a double-blind, randomized, placebo-controlled clinical trial (n=38) evaluating royal jelly + green propolis combination in hemodialysis patients over 2 months. Additional studies include a clinical trial on glycemic markers (showing no improvement), a meta-analysis on inflammation markers (hs-CRP), and a randomized trial in renal cell carcinoma patients. Most evidence remains preliminary, derived from in vitro and animal studies rather than large-scale human trials.

Clinical Summary

A randomized clinical trial (n=38) in chronic kidney disease patients demonstrated that Royal Jelly Propolis supplementation produced significant reductions in total cholesterol and prevented pathological increases in serum urea and creatinine, suggesting nephroprotective and cardiovascular benefits (moderate evidence). In vitro studies have confirmed significant inhibitory effects against Encephalitozoon species, indicating antiparasitic and antimicrobial potential, though these findings have not yet been validated in human trials. The clinical evidence base remains limited by small sample sizes and a lack of large-scale, multi-center randomized controlled trials. Current findings are promising but should be interpreted cautiously pending replication in larger, more diverse populations.

Nutritional Profile

Royal Jelly Propolis from Apis mellifera is a complex bioactive matrix combining compounds from both royal jelly and propolis. Royal jelly component contains approximately 60-70% water (fresh weight), with dry matter comprising: proteins 27-41% (including major royal jelly proteins MRJPs 1-9, particularly apalbumin-1/MRJP1 at ~48% of total protein), carbohydrates 28-30% (primarily fructose and glucose), lipids 8-19% (dominated by 10-hydroxy-2-decenoic acid/10-HDA at 1.4-2.1% fresh weight — the principal bioactive fatty acid with antimicrobial and immunomodulatory properties), and ash ~1.5%. Contains B-complex vitamins including pantothenic acid (B5, ~52 mg/100g dry weight), pyridoxine (B6, ~2.4 mg/100g), thiamine (B1, ~1.5 mg/100g), riboflavin (B2, ~1.7 mg/100g), niacin (~91 mg/100g), biotin (~0.16 mg/100g), and folate (~0.16 mg/100g); also contains acetylcholine (~1 mg/g). Propolis component contributes polyphenols (50-60% of dry propolis): flavonoids including pinocembrin (up to 10% of extract), chrysin, galangin, quercetin, kaempferol, and apigenin; phenolic acids including caffeic acid phenethyl ester (CAPE, 3-5% of temperate propolis), ferulic acid, and p-coumaric acid; aromatic esters including artepillin C (in Brazilian green propolis). Propolis also provides resins and waxes (30-40%), essential oils (5-10%), and trace minerals including zinc (~5 mg/100g), manganese, iron, and calcium. Combined bioactive compounds responsible for reported cardiovascular and antimicrobial effects include 10-HDA (lipid-lowering via PPAR pathway modulation), CAPE (NF-κB inhibition), and flavonoid antioxidants with DPPH radical scavenging capacity reported at IC50 ~15-30 μg/mL for ethanolic propolis extracts. Bioavailability of royal jelly proteins is moderate due to partial gastric digestion; 10-HDA shows good oral absorption. Polyphenols from propolis have variable bioavailability (10-40%) dependent on gut microbiome metabolism; lipophilic compounds benefit from co-administration with dietary fats.

Preparation & Dosage

Clinically studied dosage: 100 mg royal jelly + 500 mg propolis daily (as EPP-AF® standardized extract), administered as four capsules daily. In vitro research used propolis at 62.5–250 µg/mL and royal jelly at 6.25–25 mg/mL (non-cytotoxic ranges). Standardization includes ISO12824 standards for royal jelly and HPLC analysis for propolis. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, vitamin C, omega-3 fatty acids, CoQ10, resveratrol

Safety & Interactions

Royal Jelly Propolis is generally well tolerated at typical supplemental doses, but individuals with known bee product allergies—including honey, pollen, or propolis hypersensitivity—are at significant risk of allergic reactions ranging from contact dermatitis to anaphylaxis. It may potentiate the anticoagulant effects of warfarin due to flavonoid-mediated inhibition of platelet aggregation and CYP2C9 enzyme activity, necessitating caution and INR monitoring in patients on anticoagulant therapy. Pregnant and breastfeeding women should avoid use due to insufficient safety data, and individuals with asthma have a higher documented incidence of adverse respiratory reactions. Those taking antihypertensive or lipid-lowering medications should consult a healthcare provider, as additive effects on blood pressure and cholesterol may require dosage adjustments.